These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 32290325)
1. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death. Park HK; Han BR; Park WH Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325 [TBL] [Abstract][Full Text] [Related]
2. Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine. Cavaliere V; Lombardo T; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA Eur J Cancer; 2014 Dec; 50(18):3243-61. PubMed ID: 25446377 [TBL] [Abstract][Full Text] [Related]
3. Combination of arsenic trioxide and chemotherapy in small cell lung cancer. Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Han YH; Kim SZ; Kim SH; Park WH Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383 [TBL] [Abstract][Full Text] [Related]
5. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide. Chien CW; Yao JH; Chang SY; Lee PC; Lee TC Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949 [TBL] [Abstract][Full Text] [Related]
6. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair. Luo Q; Li Y; Deng J; Zhang Z Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines. Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085 [TBL] [Abstract][Full Text] [Related]
8. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma. Lam SK; Leung LL; Li YY; Zheng CY; Ho JC Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399 [TBL] [Abstract][Full Text] [Related]
9. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo. Shen L; Zhang G; Lou Z; Xu G; Zhang G BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727 [TBL] [Abstract][Full Text] [Related]
10. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. Lee PC; Kakadiya R; Su TL; Lee TC Neoplasia; 2010 May; 12(5):376-87. PubMed ID: 20454509 [TBL] [Abstract][Full Text] [Related]
11. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest. Hassani S; Ghaffari SH; Zaker F; Mirzaee R; Mardani H; Bashash D; Zekri A; Yousefi M; Zaghal A; Alimoghaddam K; Ghavamzadeh A Ann Hematol; 2013 Sep; 92(9):1207-20. PubMed ID: 23645216 [TBL] [Abstract][Full Text] [Related]
12. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform. Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis. Han BR; You BR; Park WH Oncol Rep; 2013 Dec; 30(6):2999-3005. PubMed ID: 24064712 [TBL] [Abstract][Full Text] [Related]
14. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. Tan M; Zhang Q; Yuan X; Chen Y; Wu Y J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525 [TBL] [Abstract][Full Text] [Related]
15. Auranofin inhibits the proliferation of lung cancer cells via necrosis and caspase‑dependent apoptosis. Cui XY; Park SH; Park WH Oncol Rep; 2020 Dec; 44(6):2715-2724. PubMed ID: 33125149 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation. Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607 [TBL] [Abstract][Full Text] [Related]
17. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species. Mesbahi Y; Zekri A; Ghaffari SH; Tabatabaie PS; Ahmadian S; Ghavamzadeh A Eur J Pharmacol; 2018 Sep; 834():65-76. PubMed ID: 30012499 [TBL] [Abstract][Full Text] [Related]
18. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma. Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794 [TBL] [Abstract][Full Text] [Related]
19. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Du S; Liu K; Gao P; Li Z; Zheng J Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648 [TBL] [Abstract][Full Text] [Related]
20. PX-12 inhibits the growth of A549 lung cancer cells via G2/M phase arrest and ROS-dependent apoptosis. You BR; Shin HR; Park WH Int J Oncol; 2014 Jan; 44(1):301-8. PubMed ID: 24172913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]